Point72 Asset Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-248
Closed -$6.17K 2964
2023
Q2
$6.17K Buy
+248
New +$7.27K ﹤0.01% 1948

Other funds holding OMIC

Point72 Asset Management's OMIC Position: Q3 2023 in Review

Point72 Asset Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q3 2023, closing a stake of 248 shares — an estimated $6.17K sold.

Point72 Asset Management first reported a position in OMIC in Q2 2023 and held it in 1 quarter. The position peaked at $6.17K in Q2 2023. 48 funds tracked by Wall St. Rank hold OMIC as of Q3 2023.

  • Point72 Asset Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Point72 Asset Management sold 248 Singular Genomics Systems, Inc. Common Stock shares in Q3 2023, an estimated $6.17K.
  • Point72 Asset Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Point72 Asset Management's Singular Genomics Systems, Inc. Common Stock position peaked at $6.17K in Q2 2023.
  • 48 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q3 2023.

Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.